Precision BioSciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $576 | $49,898 | $17,584 | $7,038 |
Gross Profit | -434 | 48,516 | 16,157 | 5,482 |
EBITDA | -15,158 | 34,691 | 10,589 | -11,299 |
EBIT | -16,169 | 33,309 | 9,162 | -12,855 |
Net Income | -16,425 | 32,749 | 8,588 | -16,289 |
Net Change In Cash | 576 | 49,898 | 17,584 | 7,038 |
Free Cash Flow | -5,951 | -14,897 | -19,067 | -8,418 |
Cash | 98,752 | 123,571 | 137,766 | 116,678 |
Basic Shares | 7,287 | 7,011 | 5,063 | 4,010 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $48,727 | $25,098 | $115,529 | $24,285 |
Gross Profit | 40,472 | 16,094 | 115,529 | 24,285 |
EBITDA | -32,042 | -62,794 | -20,273 | -99,193 |
EBIT | -40,297 | -71,798 | -30,470 | -109,006 |
Net Income | -61,319 | -122,908 | -30,918 | -109,006 |
Net Change In Cash | 48,727 | 25,098 | 115,529 | 24,285 |
Cost of Revenue | 45,913 | 53,865 | -91,088 | |
Free Cash Flow | -86,392 | -49,072 | -16,656 | -92,417 |
Cash | 116,678 | 189,576 | 143,663 | 89,798 |
Basic Shares | 3,841 | 2,929 | 1,956 | 1,734 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.25 |
2024-06-30 | $4.67 |
2024-03-31 | -$0.35 |
2023-12-31 | -$4.06 |
